Morphological and cytochemical characteristics of leukaemic promyelocytes

Best Practice and Research: Clinical Haematology

Volumn 16, Issue 3, 2003, Pages 349-355

  Liso, V ^a   Bennett, J ^b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

APL; Cytochemistry of APL; Morphology of APL cells

Indexed keywords

CHLOROACETIC ACID; ESTERASE; PEROXIDASE; RETINOIC ACID RECEPTOR ALPHA; ZINC FINGER PROTEIN; MYELOPEROXIDASE;

ARTICLE; CANCER CLASSIFICATION; CELL STRUCTURE; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CLINICAL FEATURE; CYTOCHEMISTRY; CYTOPATHOLOGY; EOSINOPHILIC LEUKEMIA; GENE FUSION; HUMAN; MAST CELL LEUKEMIA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; BASOPHIL; CANCER CELL; CELL DIFFERENTIATION; DISEASE CLASSIFICATION; GRANULOCYTE; HISTOPATHOLOGY; MEGAKARYOCYTE; REVIEW;

EID: 0041327733     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6926(03)00061-6     Document Type: Review

References (31)

1. Bennett JM, Catovsdy D, Daniel MT et al. Proposals for the classification of the acute leukaemias. French - American - British (FAB) co-operative group. British Journal of Haemotology 1976; 33: 451-458.
2. Bennett JM, Catovsky D, Daniel MT et al. Variant form of hypergranular promyelocytic leukaemia (M3). British Journal of Haematology 1980; 44: 169-170.
3. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Annals of Internal Medicine 1985; 103: 620-625.
4. Rowley JD, Golomb HM & Dougherty C. 15/17 translocation, a consistent chromosomal change in acute promyelocytic leukaemia. Lancet 1977; i: 549-550.
5. Warrell Jr. RP, de The H, Wang ZY et al. Acute promyelocytic leukemia. New England Journal of Medicine 1993; 329: 177-189.
6. Arnould C, Philippe C, Bourdon V et al. The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Human Molecular Genetics 1999; 8: 1741-1749.
7. Jonveaux P, Le Coniat M, Derre J et al. Chromosome microdissection in leukemia: a powerful tool for the analysis of complex chromosomal rearrangements. Genes Chromosomes and Cancer 1996; 15: 26-33.
8. Grimwade D, Biondi A, Mozziconacci MJ et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogenetique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED I European Community-Concerted Action 'Molecular Cytogenetic Diagnosis in Haematological Malignancies'. Blood 2000; 96: 1297-1308.
9. Jansen JH & Lowenberg B. Acute promyelocytic leukemia with a PLZF-RARα fusion protein. Seminars in Hematology 2001; 38: 37-41.
10. Foley R, Soamboonsrup P & Carter RF. CD34-positive acute promyelocytic leukemia is associated with leukocytosis, microgranular/hypogranular morphology, expression of CD2 and bcr3 isoform. American Journal of Hematology 2001; 67: 34-41.
11. Avvisati G, Lo Coco F & Mandelli F. Acute promyelocytic leukemia: clinical and morphologic features and prognostic factors. Seminars in Hematology 2001; 38: 4-12.
12. Chim CS, Lam CC, Wong KF et al. Atypical clasts and bone marrow necrosis associated with near-triploid relapse of acute promyelocytic leukemia after arsenic trioxide tratment. Human Pathology 2002; 33: 849-851.
13. Bennett JM, Catovsky D, Daniel MT et al. Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17). Leukemia 2000; 14: 1197-1200.
14. Sainty D, Liso V, Cantu-Raynoldi A et al. A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements. Blood 2000; 96: 1287-1296.
15. Castoldi GL, Liso V, Specchia G et al. Acute promyelocytic leukemia: morphological aspects. Leukemia 1994; 8: 1441-1446.
16. Fukuno K, Tsurumi H & Yoshikawa T. A variant form of acute promyelocytic leukemia with marked myelofibrosis. International Journal of Hematology 2001; 74: 322-326.
17. Gotoh H, Murakami S, Oku N et al. Translocations t(15;17) and t(9;14)(q34;q22) in a case of acute promyelocytic leukemia with increased number of basophils. Cancer Genetics and Cytogenetics 1988; 36: 103-107.
18. McKenna RW, Parkin J, Bloomfield CD et al. Acute promyelocytic leukaemia: a study of 39 cases with identification of a hyperbasophilic microgranular variant. British Journal of Haematology 1982; 50: 201-214.
19. Tallman MS, Hakimian D, Snower D et al. Basophilic differentiation in acute promyelocytic leukemia. Leukemia 1993; 7: 521-526.
20. Umeda M, Nojima Z, Yamaguchi R et al. Two cases of acute promyelocytic leukemia with marked basophilia-a variant type of APL with the capability of differentiating into basophils. Rinsho Ketsueki 1987; 28: 2004-2009.
21. Yu RQ, Huang W, Chen SJ et al. A case of acute eosinophilic granulocytic leukemia with PML/RAR alpha fusion gene expression and response to all-trans retinoic acid. Leukemia 1997; 11: 609-611.
22. Liso V, Troccoli G & Grande M. Cytochemical study of acute promyelocytic leukemia. Blut 1975; 30: 261-268.
23. Castoldi GL & Cuneo A. Special cytological subtypes of acute myeloid leukemias and myelodysplastic syndromes. Baillière's Clinical Haematology 1996: 19-33.
24. Kubonishi I, Fujishita M, Niiya K et al. Basophilic differentiation in acute proromyelocytic leukemia. Nippon Ketsueki Gakkai Zasshi 1985; 48: 1390-1396.
25. Koken MH, Daniel MT, Gianni M et al. Retinoic acid, but not arsenic trioxide, degrades the PLZF/ RARalpha fusion protein, without inducing terminal differentiation or apoptosis, in a RA-therapy resistant t(11;17)(q23;q21) APL patient. Oncogene 1999; 18: 1113-1118.
26. Neame PB, Soamboonsrup P, Leber B et al. Morphology of acute promyelocytic leukemia with cytogenetic or molecular evidence for the diagnosis: characterization of additional microgranular variants. American Journal of Hematology 1997; 56: 131-142.
27. Allford S, Grimwade D, Langabeer S et al. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party. British Journal of Haematology 1999; 105: 198-207.
28. Fenaux P, Chomienne C & Degos L. Acute promyelocytic leukemia: biology and treatment. Seminars in Oncology 1997; 24: 92-102.
29. Tallman MS, Andersen JW, Schiffer CA et al. All-trans-retinoic acid in acute promyelocytic leukemia. New England Journal of Medicine 1997; 337: 1021-1028.
30. Cassinat B, Chevret S, Zassadowski F et al. In vitro all-trans retinoic acid sensitivity of acute promyelocytic leukemia blasts: a novel indicator of poor patient outcome. Blood 2001; 98: 2862-2864.
31. Tallman MS, Andersen JW & Schiffer CA. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 2002; 100: 4298-4302.